Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             599 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 ABSTRACT REVIEWERS
72-73 S p. ii
artikel
2 ABSTRACT REVIEWERS
72-73 S p. iii
artikel
3 Access to 18F-labeled FAP inhibitor variants via [18F]SuFEx reaction Kogler, Jürgen

72-73 S p. S16
artikel
4 225Ac labeled anti-HER2 2Rs15d sdAb as a potential therapeutic for targeted alpha therapy – an in vitro and in vivo evaluation Rodak, Magdalena

72-73 S p. S33
artikel
5 A clickable C-glycosyl scaffold for RGD peptide dimer labelling and application in bimodal [18F]PET/NIRF imaging Jouad, Kamal

72-73 S p. S42
artikel
6 A comparison of rhenium isolation and tungsten recovery methods from bulk tungsten targets Charles, Anster

72-73 S p. S104
artikel
7 A convenient tritiation strategy for tetrazines Bidesi, Natasha

72-73 S p. S90
artikel
8 Actinium-225 labeling of DOTATATE and DOTA-JR11 for the treatment of SSTR2-positive tumors Handula, Maryana

72-73 S p. S191
artikel
9 Advances in the automation technologies within LARAMED project Martini, Petra

72-73 S p. S21
artikel
10 A facile 18F radiochemistry of making (-)-[18F]TZ8024 for imaging VAChT and initial metabolite analysis in rat plasma and brain Zhao, Haiyang

72-73 S p. S39
artikel
11 A facile radiosynthesis of [18F]FBA-Pep42, a cyclic peptide targeting glucose-regulated protein 78 (GRP78) Yang, Hao

72-73 S p. S72
artikel
12 A facile synthesis of beta-amyloid PET imaging agent [18F]Florbetaben Akula, Hari

72-73 S p. S85
artikel
13 A fluorescent probe as a lead compound for a potential α-syn PET tracer: design and development of a library of RB1 derivatives Di Nanni, Adriana

72-73 S p. S94
artikel
14 Albumin binders: a potential strategy for enhanced treatment of NETs using SSTR2 antagonists Koustoulidou, Sofia

72-73 S p. S191-S192
artikel
15 Al18F-Radiolabeling of PSMA-11 in a media of protic ionic liquids Antuganov, Dmitrii

72-73 S p. S76-S77
artikel
16 ALISI – automated light-induced synthesis of 89Zr-labelled antibodies for immuno-PET Klingler, Simon

72-73 S p. S5-S6
artikel
17 Alternate radiohalogens for trametinib PET imaging Pratt, Edwin

72-73 S p. S52
artikel
18 Alternative protective group strategy for the radiosynthesis of Flortaucipir 18F Xiong, Hui

72-73 S p. S88
artikel
19 A multi-modality platform employing supramolecular chemistry to radiolabel antibodies d’Orchymont, Faustine

72-73 S p. S27-S28
artikel
20 An approach towards reverse generator system for 99mTc separation from LSA 99Mo Cieszykowska, Izabela

72-73 S p. S97
artikel
21 An effective process for radiolabelling of bioactive amines from 2,2-difluoro-2-[18F]Fluoro-ethyl 4-methylbenzenesulfonate, a versatile tool for 18F-radiotracer development Maqbool, Mudasir

72-73 S p. S82
artikel
22 A new in silico approach to revolutionize CNS PET tracer design and enhance translational success Jackson, Isaac

72-73 S p. S24-S25
artikel
23 A new paradigm of cancer immunotherapy based on [18F]FDG and anti-PD-L1 mAb combination Wen, Xuejun

72-73 S p. S219-S220
artikel
24 A new prospective CB2 receptor tracer based on a 18F labelled naphthyridine core: radiosynthesis and microPET imaging data Pascali, Giancarlo

72-73 S p. S35
artikel
25 A new rhenium/technetium-99m complex bearing a quinazoline derivative and 2-picolylamine-N-acetic acid for EGFR imaging Makrypidi, Konstantina

72-73 S p. S15
artikel
26 An improved separation scheme for 44Sc purification from proton irradiated calcium Kurakina, Elena

72-73 S p. S92
artikel
27 An improved synthesis of [18F]VAT precursor for a one-step radiofluorination Hu, Bao

72-73 S p. S85-S86
artikel
28 An interleukin-2 derived small peptide probe for CD25 targeted PET/CT imaging of activated T cells Wang, Shuailiang

72-73 S p. S7
artikel
29 A novel flexible pipetting-based platform for automated microvolume radiochemistry Lu, Yingqing

72-73 S p. S58-S59
artikel
30 A novel fluorine-18 labeled P2Y12 receptor PET tracer for imaging of anti-inflammatory microglia van der Wildt, Berend

72-73 S p. S108-S109
artikel
31 A novel PET ligand for imaging monoacylglycerol lipase in naïve and mouse models of Alzheimer’s disease Rong, Jian

72-73 S p. S21
artikel
32 A novel radioiodinated probe for diagnosis of systemic amyloidosis based on thioflavin-T and Congo-red hybrid structure Haratake, Yoshie

72-73 S p. S54-S55
artikel
33 A novel radiotracer for imaging autotaxin: [18F]THPDPATX Ebrahimi, Edris

72-73 S p. S186
artikel
34 A novel tetrahydrothienopyridine-based PET tracer for P2Y12 receptor imaging in the brain Joseph, Emanuel

72-73 S p. S47
artikel
35 A pilot study of [18F]AlF-HER2 Affibody in HER2-positive breast cancer patients Guo, Xiaoyi

72-73 S p. S49
artikel
36 Application of ionic liquids for ring-opening of non-activated aziridines with [11C]CO2 Lindberg, Anton

72-73 S p. S28-S29
artikel
37 Application of quaternary 1,4-diazabicyclo[2.2.2]octan (DABCO) salts for SN2 “minimalist” radiofluorination Keuthen, Yannick

72-73 S p. S49
artikel
38 Apramer-based synthesis of radiopharmaceuticals Belugin, Kirill

72-73 S p. S179
artikel
39 A pyrene-phthalocyanine conjugate for dual Cherenkov radiation-induced near-infrared luminescence imaging and photodynamic therapy lioret, Vivian

72-73 S p. S105-S106
artikel
40 A quest for simplicity: automated cassette-based purification of [61Cu]CuCl2 from solid Ni targets using a single time-list Svedjehed, Johan

72-73 S p. S170
artikel
41 Aryliodonium ylides as efficient precursors for astatine-211 labeling Maingueneau, Clémence

72-73 S p. S174-S175
artikel
42 Arylpalladium complexes on solid supports for convenient last-step labelling of bioconjugates by [11C]CO Hermange, Philippe

72-73 S p. S72
artikel
43 A simplified radiosynthesis of [18F]FMPEP for imaging CB1 receptors Pees, Anna

72-73 S p. S83
artikel
44 A single-pot photo-induced reaction for zirconium-89 radioimmunoPET agents: an efficient approach for translation of radiolabeled antibodies for human use Fong, Cyril

72-73 S p. S119-S120
artikel
45 Astatine-211 based PSMA-inhibitors for targeted alpha-therapy of prostate cancer Poulie, Christian

72-73 S p. S60
artikel
46 A structure-activity relationship study of bimodal BODIPY-labeled PSMA-targeting bioconjugates Stemler, Tobias

72-73 S p. S26-S27
artikel
47 A study to obtain a highly reproducible radiochemical yield (RCY) in the PSMA-11 radiolabeling Iudicello, Antonella

72-73 S p. S142-S143
artikel
48 At-211-labeled L-tyrosine derivatives via neopentyl scaffold for targeted α-therapy Kaizuka, Yuta

72-73 S p. S12-S13
artikel
49 A trifluoroborate (BF3) radioprosthetic group bearing FAP-targeting ligand for facile labeling with 18F via the 18F-19F isotope exchange reaction: synthesis, radiolabeling and in vivo evaluation Bendre, Shreya

72-73 S p. S179-S180
artikel
50 Au@Pt core-shell nanoparticle bioconjugates for Auger electron radiotherapy – preliminary studies Wawrowicz, Kamil

72-73 S p. S82-S83
artikel
51 Author Index
72-73 S p. S109-S114
artikel
52 Author Index
72-73 S p. S223-S235
artikel
53 Automated 18F-Al-radiolabelling optimization of PSMA-11 for PET imaging using a design of experiments approach Wagner, Laurène

72-73 S p. S138-S139
artikel
54 Automated multidoses production of [68Ga]PentixaFor in general purpose commercial module and its preclinical evaluation in lymphoma model Sahu, Sudeep

72-73 S p. S211
artikel
55 Automated production of [18F]AldoView: first translation of a sulfonium salt precursor to GMP Sirindil, Fatih

72-73 S p. S137
artikel
56 Automated production of sodium [11C]butyrate Pakula, Ryan

72-73 S p. S70-S71
artikel
57 Automated purification of 18F-compounds by semi-preparative supercritical fluid chromatography (SFC) Maindron, Nicolas

72-73 S p. S22-S23
artikel
58 Automated radiolabeling of [68Ga]Ga-DOTATOC using the iMiDEV™ automated microfluidic radiosynthesizer Chandrashekara, Hemantha Kumara

72-73 S p. S122-S123
artikel
59 Automated radiosynthesis of [18F]AlF-FAPI-42 Gröner, Benedikt

72-73 S p. S61-S62
artikel
60 Automated radiosynthesis of [18F]AV-45 using Elixys FLEX/CHEM and PURE/FORM synthesis system Miller, William

72-73 S p. S132
artikel
61 Automated radiosynthesis of [18F]DOPA and [18F]FMT via copper-mediated nucleophilic F-18 Fluorination of arylstannanes on a new synthesizer Nagachinta, Surasa

72-73 S p. S133-S134
artikel
62 Automated radiosynthesis of 6-[18F]F-L-DOPA from a boronic precursor on NEPTIS® module Maindron, Nicolas

72-73 S p. S129
artikel
63 Automated radiosynthesis of meta-[18F]Fluorobenzylguanidine from a diaryliodonium salt precursor on NEPTIS® module Maindron, Nicolas

72-73 S p. S131
artikel
64 AUTOmated radiosynthesis of para-[131I]Iodo-L-phenylalanine on NEPTIS® module Maindron, Nicolas

72-73 S p. S130-S131
artikel
65 Automated radiosynthesis of the 18F-labeled BF2-chelated tetraaryl-azadipyrromethenes photosensitizer using isotopic exchange Kawamura, Kazunori

72-73 S p. S81-S82
artikel
66 Automated synthesis and quality control of [18F]FFNP with GMP compliance Kim, Dong Hyun

72-73 S p. S127-S128
artikel
67 Automated synthesis of D-[3-11C]Alanine on the Sofie Biosciences Elixys Flex/Chem Simpson, Spenser

72-73 S p. S136-S137
artikel
68 Automated synthesis of 16-[131I]iodohexadecanoic acid: a lymphatic leakage tracer Plhak, Elisabeth

72-73 S p. S59-S60
artikel
69 Automation of 4-[18F]fluorogabapentin radiosynthesis Zhou, Yu-Peng

72-73 S p. S66
artikel
70 Automation of two-step synthesis of [18F]FP-TMP using Trasis AllinOne Lee, Hsiaoju

72-73 S p. S127
artikel
71 3-Aza-6-[18F]fluoro-isatoic anhydrides ([18F]AFIAs) - novel prosthetic groups for indirect radiolabeling Willmann, Michael

72-73 S p. S28
artikel
72 131Ba as a promising SPECT-diagnostic match for 223/224Radium Reissig, Falco

72-73 S p. S95
artikel
73 Behind the scenes of Ga-68-Trivehexin development: unique structure-activity relationships Quigley, Neil

72-73 S p. S208-S209
artikel
74 8-Bicycloalkyl-CPFPX derivatives as potent and selective tools for PET imaging of the A1 adenosine receptor Holschbach, Marcus

72-73 S p. S26-S27
artikel
75 Binding of [64Cu]DOTATATE beyond the BBB Andersen, Ida

72-73 S p. S172-S173
artikel
76 Bioconjugates labeled with Auger electron emitter: 135La, as potential therapeutic radiopharmaceutical Walczak, Rafał

72-73 S p. S159
artikel
77 Bioconjugates of 103Pd/103mRh in-vivo generator for targeted Auger electron therapy Gieraltowska, Joanna

72-73 S p. S188-S189
artikel
78 Biodistribution of a 67Ga-labeled anti-TNF VHH single-domain antibody containing a bacterial albumin-binding domain (Zag) Morais, Maurício
2014
72-73 S p. e44-e48
nvt p.
artikel
79 Biological evaluation of [18F]FDG-Tz as a tracer candidate for pretargeted PET imaging Auchynnikava, Tatsiana

72-73 S p. S71-S72
artikel
80 Biological evaluation of 111In-clickable complexes for cancer theranostics D’Onofrio, Alice

72-73 S p. S188
artikel
81 Bispecific antibody-based radiopharmaceutical towards phosphorylated TDP-43 Pakula, Ryan

72-73 S p. S103
artikel
82 Borylation and 18F-Fluorination of arenes mediated by Lewis-acid organocatalysts Garcia, Raul Perez

72-73 S p. S84
artikel
83 Brain energetics by biomedical modalities Tiwari, Anjani

72-73 S p. S108
artikel
84 Bringing personalized medicine to the next level: RANKL immuno-PET imaging using [64Cu]Cu-NOTA-anti-RANKL-Fab fragments Dewulf, Jonatan

72-73 S p. S184-S185
artikel
85 Bucherer-Bergs multicomponent reaction with [11C]CO2, a facile and divergent synthesis of 11C-labelled hydantoins van der Aa, Frank

72-73 S p. S75
artikel
86 Capsular reformulation of the PET radiopharmaceutical [18F]FTHA for oral administration Moerlein, Stephen

72-73 S p. S144
artikel
87 Carbamoyl fluoride as a potential new tag for 18F-labeling Bonnefoy, Clémence

72-73 S p. S77-S78
artikel
88 Carbon-11 carboxylation of trialkoxysilane and trimethylsilane derivatives using [11C]CO2 Bongarzone, Salvatore

72-73 S p. S68
artikel
89 Carbon-11 labelled isocyanides: new versatile building blocks to access novel PET tracers Bonnemaire, Coralie

72-73 S p. S27-S28
artikel
90 11C-Carbonylation using TracerLab FX Synthesis modules Shao, Xia

72-73 S p. S136
artikel
91 [11C]Carboxylated tetrazines for facile labeling of trans-cyclooctene-functionalized macromolecules Vázquez, Rocío García

72-73 S p. S71-S72
artikel
92 11C-Carboxylation via organic photoredox-catalyzed isotopic exchange Munch, Maxime

72-73 S p. S29
artikel
93 CD46 targeted, Actinium-225 labelled antibody for treatment of prostate cancer xenografts Bidkar, Anil

72-73 S p. S31
artikel
94 Centralized GMP production of [90Y]Y-PentixaTher for clinical trials Berroteran-Infante, Neydher

72-73 S p. S121
artikel
95 C-H activation: optimisation of palladium mediated 11C methylation Ariztia, Julen

72-73 S p. S70
artikel
96 Characterization of a PET radioligand suitable for imaging and quantification of sigma-2 receptor in the primate brain Zheng, Ming-Qiang

72-73 S p. S5
artikel
97 Characterization of new FSHβ-derived peptide probes for the validation of FSHR as a new prognostic and predictive biomarker in primary and metastatic cancers Carpanese, Debora

72-73 S p. S89
artikel
98 Chelator-based non-peptidic radiotracers for PET imaging of PD-L1 with copper-64 Krutzek, Fabian

72-73 S p. S38
artikel
99 Cholesterol-depleting drugs for HER2-targeted radioimmunotherapy of patient-derived esophagogastric (EG) cancer Rao, Yi

72-73 S p. S210-S211
artikel
100 Choosing the right molar activity of an 122I-labeled irreversible inhibitor of transglutaminase 2 for quantitative expression profiling in tissues Donat, Cornelius

72-73 S p. S220
artikel
101 11C-labelled oxadiazoles via 11C-labelled acyl amidines through a one-pot, two-step reaction Rydfjord, Jonas

72-73 S p. S74
artikel
102 Combined PD-L1–targeted radionuclide therapy with immunotherapy in two models of colorectal cancer Wen, Xuejun

72-73 S p. S33
artikel
103 Comparative analysis of multiple myeloma treatment by CD138 antigen targeting with bismuth-213 and Melphalan chemotherapy Gouard, S.
2014
72-73 S p. e30-e35
nvt p.
artikel
104 Comparative evaluation by SPECT and PET imaging of two immuno-pre-targeting systems in an in vivo model of triple negative breast tumours with anti-EGFR antibodies Briat, Arnaud

72-73 S p. S204-S205
artikel
105 Comparative evaluation of 177Lu-DOTATATE and 90Y-DOTATATE in SSTR II overexpressing Xenograft models for treatment of variable volume neuroendocrine tumours Tawate, Megha

72-73 S p. S213-S214
artikel
106 Comparative in vivo biodistribution and dosimetry in non-human primate of the fibroblast activation protein radiotracers [68Ga]Ga-FAPI-04, [68Ga]Ga-FAPI-46 and [18F]FAPI-74 Tran, Thuy

72-73 S p. S216-S217
artikel
107 Comparison of a radiolabeled somatostatin agonist with an antagonist using the SSTR2 expressing cell line BON-1S in 2D and 3D models Sihver, Wiebke

72-73 S p. S212-S213
artikel
108 Comparison of biodistribution according to administration route for the development of liposome therapeutics Yoo, Ran Ji

72-73 S p. S165
artikel
109 Comparison of cyclotron produced manganese-52 from natural chromium and vanadium targets Nielsen, Karin Michaelsen

72-73 S p. S171-S172
artikel
110 Comparison of DOTA, NODAGA and 15-5 macrocycles as chelators for 64Cu-labelling of immunoconjugates Maisonial-Besset, Aurélie

72-73 S p. S153-S154
artikel
111 Comparison of Evans Blue vs 4-(p-iodophenyl)butyric acid albumin binding moieties for lutetium-177-labeled LLP2A derivatives as theranostic agents for metastatic melanoma Pun, Michael

72-73 S p. S61
artikel
112 Comparison of [68Ga]Ga precursors for blood cell radiolabeling Bouvry, Christelle

72-73 S p. S57
artikel
113 Computational design, synthesis and radiolabelling of a novel octacoordinate chelator for 89Zr Klingler, Simon

72-73 S p. S45-S46
artikel
114 Conception of Nanoparticles as Diagnostic Agents Mignet, Nathalie

72-73 S p. S2-S3
artikel
115 Contents 2014
72-73 S p. IBC-
1 p.
artikel
116 Convenient preparation of 18F-labeled human insulin by Pd-catalyzed S-arylation Humpert, Swen

72-73 S p. S116-S117
artikel
117 Copper-61 as an alternative to Gallium-68 for radiopharmaceutical production: feasibility study and scale-up for clinical doses Fonseca, Alexandra

72-73 S p. S21-S22
artikel
118 Copper catalyzed radiobromination of boronic pinacol esters: utility in PARP inhibitor synthesis Mixdorf, Jason

72-73 S p. S175
artikel
119 Copper-61 from liquid targets: optimized purification for GMP labelling Fonseca, Alexandra

72-73 S p. S98-S99
artikel
120 Copper-mediated 18F-fluorination of boroxines: a systematic optimization study Bolik, Kim-Viktoria

72-73 S p. S35-S36
artikel
121 Copper mediated radiocyanation of aryl halides Sharninghausen, Liam

72-73 S p. S29-S30
artikel
122 11C-Radiolabeling of α-amino acids via aldehyde-promoted isotopic exchange reaction Munch, Maxime

72-73 S p. S29
artikel
123 C(sp3)-H functionalization for access to [11C]amino acids Edgar, Fraser

72-73 S p. S68-S69
artikel
124 64Cu-DOTHA2-PSMA, a novel theranostic agent for prostate cancer and its preclinical animal evaluation Milot, Marie-Christine

72-73 S p. S105
artikel
125 Cyclotron production of gallium-68 from liquid target: routine production of 68Ga-labelled radiotracers Uhlending, Antje

72-73 S p. S151
artikel
126 Cyclotron-production of Mn-52: an update on the METRICS project Martini, Petra

72-73 S p. S169-S170
artikel
127 Cyclotron production of the 64Cu theranostic radiometal using a novel 68Zn sealed solid target Nelson, Bryce

72-73 S p. S171
artikel
128 Cyclotron production of the theranostic pair 133/135La for nuclear medicine Nelson, Bryce

72-73 S p. S2-S3
artikel
129 Demonstrating peptide based nanoconstructs as emerging theranostic biomolecules Khan, Irfan

72-73 S p. S87-S88
artikel
130 Demonstration of intracellular pH-weighting PET imaging using a new-type PET probe responsible for monoacylglycerol lipase activity in the brain Yamasaki, Tomoteru

72-73 S p. S112-S113
artikel
131 De novo design of alpha-synuclein small molecule PET tracers Korat, Spela

72-73 S p. S97
artikel
132 De novo design of lead structures for P2Y12 receptor tracer development using in silico methods Stéen, E. Johanna

72-73 S p. S105-S106
artikel
133 Design and synthesis of a new bifunctional chelating agent for 18F-Al/177Lu radiolabelling: theranostic approach Wagner, Laurène

72-73 S p. S12-S13
artikel
134 Design and synthesis of novel heptadentate chelates for 89Zr-radiolabelling of antibodies Guillou, Amaury

72-73 S p. S7
artikel
135 Design space approach to optimise the [68Ga]Ga-Pentixafor radiolabelling process Kaufmann, Jens

72-73 S p. S60
artikel
136 Detecting EGFR expression in bladder cancer using [89Zr]Zr-DFO-Panitumumab immunoPET imaging Hoang, Tran

72-73 S p. S194
artikel
137 Determination of 2-chloro-2-deoxy-D-glucose, 2-fluoro-2-deoxy-D-glucose, and glucose in [18F]Fluorodeoxyglucose by capillary electrophoresis Antuganova, Yulia

72-73 S p. S80
artikel
138 Development and biological evaluation of 18F-labeled adenosine-A1-receptor partial agonists Evcüman, Sibel

72-73 S p. S9
artikel
139 Development and evaluation of new small molecule PET-radiotracers for the molecular imaging of inflammatory processes targeting S100A9 Steiner, Simon

72-73 S p. S44-S45
artikel
140 Development and evaluaton of a trans-cyclooctene (TCO) probe for pretargeted PET imaging Adhikari, Karuna

72-73 S p. S176
artikel
141 Development and exploration of bifunctional chelating ligands for mercury-197m/g Randhawa, Parmissa

72-73 S p. S13-S14
artikel
142 Development and in vitro evaluation of a copper-64 radiolabeled antibody for targeting the CXCR4 receptor in human multiple myeloma Métivier, Cassandra

72-73 S p. S203-S204
artikel
143 Development and preclinical evaluation of [11C]HSP990 as an Hsp90 PET brain probe and potential biomarker for diagnosis and follow up of CNS disease progression Cools, Romy

72-73 S p. S93-S94
artikel
144 Development and preclinical evaluation of PSMA-targeting trimers based on the NOTI chelating platform Martin, Sebastian

72-73 S p. S41
artikel
145 Development and preliminary evaluation of the fluorine-18 labeled benzamido-dihydroindene derivative [18F]FBAIN as a potential radiotracer for PET imaging of the chemokine receptor CXCR5 Lindemann, Marcel

72-73 S p. S200-S201
artikel
146 Development and validation of [18F]FDG dual radiosynthesis on a MX cassette with a NEPTIS® module Joyard, Yoann

72-73 S p. S128
artikel
147 Development of a 64Cu-labeled immuno-PET probe for imaging Sialyl Lewis X in breast cancer Kaur, Jatinder

72-73 S p. S221
artikel
148 Development of a dual imaging probe for bimodal PET/ two-photon NIRF imaging Jouad, Kamal

72-73 S p. S167-S168
artikel
149 Development of a [18F]PD-L1 radiotracer to profile cancer patient response to immunotherapy Zecca, Henry

72-73 S p. S189
artikel
150 Development of a highly hydrophilic 18F-tetrazine for pre-targeting approaches in PET imaging Perrio, Cecile

72-73 S p. S84
artikel
151 Development of aliphatic 18F-labeled tetrazines suitable for pretargeted PET imaging Battisti, Umberto

72-73 S p. S178-S179
artikel
152 Development of alpha particle emitting radionuclide therapy according to GMP guidelines for treatment of mCRPC Hooijman, Eline

72-73 S p. S22-S23
artikel
153 Development of a 99mTc-NTP 15-5 kit for an early clinical trial Sophie, Levesque

72-73 S p. S145
artikel
154 Development of a [99mTc]Tc-PVP nanogel for controlled release of 5-FU Ges-Naranjo, Adrian

72-73 S p. S84-S85
artikel
155 Development of a novel carbon-11 radiotracer for brain PET imaging of sulfonylurea receptors 1 Caillé, Fabien

72-73 S p. S33-S34
artikel
156 Development of a novel PET tracer for imaging of γ-8 dependent transmembrane AMPA receptor regulatory protein Yu, Qingzhen

72-73 S p. S66-S68
artikel
157 Development of a novel reversible monoacylglycerol lipase PET tracer bearing a morpholine-3-one scaffold He, Yingfang

72-73 S p. S5-S6
artikel
158 Development of a radiolabeled self-assembled nanoparticle as an imaging probe for CD44-expressing tumors Tanaka, Toshie

72-73 S p. S83-S84
artikel
159 Development of a small-molecule CXCR3 PET radiotracer for atherosclerosis imaging in live animals Alluri, Santosh Reddy

72-73 S p. S17
artikel
160 Development of a stable peptide-based PET tracer for detecting CD133-expressing cancer cells Hu, Kuan

72-73 S p. S195
artikel
161 Development of automatic synthesis method for [18F]Fluoromethyl-PBR28 using two synthesizer Cho, Yong-Hyun

72-73 S p. S123
artikel
162 Development of bispecific theranostic ligand targeting the prostate specific membrane antigen (PSMA) and gastrin releasing peptide (GRPR) receptor Bouzioti, Danai

72-73 S p. S29-S30
artikel
163 Development of 11C-Tucatinib as a potential HER2-targeting PET radiotracer Müller, Marius

72-73 S p. S206
artikel
164 Development of discoidal phospholipid bilayer nanoparticles with styrene maleic acid copolymer for diagnosis and therapy of intractable cancers Munekane, Masayuki

72-73 S p. S83
artikel
165 Development of FAP targeted radiopharmaceuticals Xu, Mengxin

72-73 S p. S221
artikel
166 Development of [18F]fluoro-4-(vinylsulfonyl)benzene for chemoselective cysteine radiofunctionalization of peptides McDaniel, James

72-73 S p. S75-S76
artikel
167 Development of 18F-labeled agonist for imaging STING in the tumor microenvironment Liu, Huanhuan

72-73 S p. S19-S20
artikel
168 Development of 18F-Labeled tetrazines for pretargeted imaging across the blood-brain barrier Shalgunov, Vladimir

72-73 S p. S103-S104
artikel
169 Development of 18F-labeled tracer for noninvasive PET imaging of the STING expression in tumor microenvironment Fang, Jianyang

72-73 S p. S187-S188
artikel
170 Development of freeze-dried kit for one-step expeditious preparation of [99mTc]Tc-PSMA-T4 Wojdowska, Wioletta

72-73 S p. S146
artikel
171 Development of freeze-dried kits for one-step expeditious formulation of [68Ga]Ga-NODAGA-JR11 Satpati, Drishty

72-73 S p. S47
artikel
172 Development of gallium coordinate nonapeptides as candidates for PET imaging of neuropeptide Y1 receptors in oncology Hetsron, Amit

72-73 S p. S116
artikel
173 Development of 125I-labeled tetrazines Bidesi, Natasha

72-73 S p. S52-S53
artikel
174 Development of 123I-labelled acrylamides as radiotracer candidates for transglutaminase 2 Laube, Markus

72-73 S p. S79-S80
artikel
175 Development of new aptamer-labeled radiopharmaceuticals Ozerskaya, Anastasia

72-73 S p. S43
artikel
176 Development of novel 64Cu-labelled antibodies for PET-CT imaging of TREM2 Shojaei, Monireh

72-73 S p. S104
artikel
177 Development of novel PSMA target therapeutic radiopharmaceuticals by modification with albumin binder Lee, Kyongkyu

72-73 S p. S198-S199
artikel
178 Development of novel sulfur-rich ligands for incorporation into mercury-197m/g radiopharmaceuticals Randhawa, Parmissa

72-73 S p. S8
artikel
179 Development of novel tripodal chelates for the stable chelation of theranostic radiolanthanides and actinides Carbo-Bague, Imma

72-73 S p. S148
artikel
180 Development of 203Pb-labeled SSTR2 radioligands for neuroendocrine tumors (NETs) imaging Chapeau, Dylan

72-73 S p. S54-S55
artikel
181 Development of peptide probes for imaging of CD206 positive macrophages in cancer Zhang, Bo

72-73 S p. S40
artikel
182 Development of PSMA-targeted vectors containing an albumin binder and a cleavable linker Murce, Erika

72-73 S p. S48-S49
artikel
183 Development of (radio)fluorinated aminobenzothiazole derivatives as potential adenosine A2A receptor ligands Renk, Dana

72-73 S p. S100-S101
artikel
184 Development of radiolabeled polymer nano- and micron-sized carriers Muslimov, Albert

72-73 S p. S86-S87
artikel
185 Development of reversible monoacylglycerol lipase PET tracers with improved brain uptake He, Yingfang

72-73 S p. S36
artikel
186 Development of silicon fluoride acceptor (SiFA)-conjugated antibodies targeting TREM2 and Poly-GA repeats as new tracers for PET imaging of neurodegenerative diseases Shojaei, Monireh

72-73 S p. S37
artikel
187 Development of site-specifically labelled single-domain antibody PET probe for monitoring PD-L1 expression in cancer Chen, Yinfei

72-73 S p. S200
artikel
188 Development of versatile dual-modality imaging probes based on a GRPR antagonist for preoperative imaging and image-guided surgery of prostate cancer Handula, Maryana

72-73 S p. S82
artikel
189 Development of 89Zr-antibody-PET imaging to evaluate improved brain targeting via transferrin receptor 1: the chelator matters Wuensche, Thomas

72-73 S p. S24
artikel
190 Development of 89Zr-radiolabeled paclitaxel-loaded polymeric micelles for potential applications in personalized treatment of triple-negative breast cancer Sadeghzadeh, Masoud

72-73 S p. S163-S164
artikel
191 Diagnostic efficacy of 68Ga-DOTAGA-Duramycin for early detection of anthracycline induced cardiotoxicity in Wistar rats Gill, Gurvinder

72-73 S p. S65-S66
artikel
192 Differential and staging diagnosis for NSCLC patients With [68Ga] Ga-DOTA-FAPI-04 and 2-[18F]FDG PET/CT Zhou, Xin

72-73 S p. S46-S47
artikel
193 Direct carbon-11 isotopic radiolabeling of Domperidone from [11C]CO2: application to in vivo brain PET imaging under P-glycoprotein inhibition Caillé, Fabien

72-73 S p. S91
artikel
194 Direct 11C-methylation of amines using cyclotron-produced [11C] CO2 Kealey, Steven

72-73 S p. S30
artikel
195 Direct 18F fluorination of covalent organic framework (COF) nanosheets for PET molecular imaging Kim, Dong Wook

72-73 S p. S161-S162
artikel
196 Direct 18F-labeling of a dimeric RGD peptide via F-nucleophilic substitution on a phosphonate prothesis Wang, Chao

72-73 S p. S76
artikel
197 DNA damage-centered signaling pathways are effectively activated during low dose-rate Auger radioimmunotherapy Piron, Bérengère
2014
72-73 S p. e75-e83
nvt p.
artikel
198 DOTA derivatives with sulfur containing side chains as an attempt to thwart the biological instability of copper labelled radiotracers Tosato, Marianna

72-73 S p. S6-S7
artikel
199 DOX-PEG-198AuNPs-PEG-Tmab: multimodal radiobioconjugate for targeted radionuclide therapy of HER2-positive cancers Zelechowska-Matysiak, Kinga

72-73 S p. S165-S166
artikel
200 Economical radiosynthesis optimization using a multi-reaction microdroplet chip platform Rios, Alejandra

72-73 S p. S65-S66
artikel
201 Editorial Board 2014
72-73 S p. IFC-
1 p.
artikel
202 Editorial Board
72-73 S p. i
artikel
203 Editorial Board
72-73 S p. i
artikel
204 Effect of dissolution and exposure of [18F]F– on nucleophilic 18F-fluorination Mou, Zhaobiao

72-73 S p. S77-S78
artikel
205 Effect of (2-hydroxypropyl)-β-cyclodextrin on the solubility and in vivo behavior of the myocardial perfusion imaging agent [18F] FRho6G-DEG Inkster, James

72-73 S p. S58
artikel
206 Efficacy and imaging evaluation of 177Lu-labeled antibody-drug conjugates as a potential theranostic agent for HER2-positive breast cancer Kim, Heejung

72-73 S p. S104-S105
artikel
207 Efficient cartridge-based synthesis of a novel [18F]tetrazine for large molecule labelling Rokka, Johanna

72-73 S p. S115
artikel
208 Efficient chelation of 134Ce/La using the macrocyclic chelators DOTA and Macropa as potential PET imaging agents Bobba, Kondapa

72-73 S p. S8-S9
artikel
209 Efficient 18F-fluorination for dimorpholinophosphinic fluoride Wang, Tao

72-73 S p. S79
artikel
210 EGSnrc Monte Carlo calculated dose distribution around brachytherapy sources Tuan, Hoang

72-73 S p. S175-S176
artikel
211 Electronic cigarette aerosol deposition of [11C]nicotine in human subjects: radiosynthesis and vaping apparatus development VanBrocklin, Henry

72-73 S p. S137-S138
artikel
212 Enabling insights into the cytochrome P450 isoform specific metabolism of radiotracers by CYP overexpressing hepatoblastoma cell lines Lemm, Sandy

72-73 S p. S66-S67
artikel
213 ENBPI ligand for 68Ga: synthesis, radiolabeling optimization, and pilot myocardial perfusion imaging with ECG-gated PET Muzzioli, Riccardo

72-73 S p. S57
artikel
214 Enhanced blood retention and tumor uptake of PSMA-targeting, 225Ac-labeled radioconjugates Reissig, Falco

72-73 S p. S30-S31
artikel
215 Epigenetic modifiers in somatostatin type 2 receptor radionuclide theranostics and early transcriptional response of mouse pheochromocytoma models Ullrich, Martin

72-73 S p. S11
artikel
216 Establishing the role of “Design of Experiments” (DoE) in the tracer development pipeline: the synthesis and evaluation of [18F] talazoparib as a case study Bowden, Gregory

72-73 S p. S78-S79
artikel
217 Evaluation of Actinium-225 radiolabeled cyclized alpha-melanocyte stimulating hormone (CycMSH) peptide for targeted alpha therapy Brown, Victoria

72-73 S p. S101
artikel
218 Evaluation of Affibody molecule Z09591 for PET imaging in fibrosis Wegrzyniak, Olivia

72-73 S p. S44
artikel
219 Evaluation of a multifunctional blood-brain barrier co-culture model prepared from rat primary brain endothelial cells and astrocytes: first results Schneider, Daniela

72-73 S p. S102-S103
artikel
220 Evaluation of an open-source 3D printed microfluidic system for the production of radiopharmaceuticals Cotton, Jonathan

72-73 S p. S123-S124
artikel
221 Evaluation of [11C]HSP990 as a PET probe for in vivo visualisation of heat shock protein 90 in tumours Narykina, Valeria

72-73 S p. S207-S208
artikel
222 Evaluation of [18F]FPy-T140 derivative PET imaging agents for CXCR4 in human cancer xenograft mouse models Phelps, Tim

72-73 S p. S20
artikel
223 Evaluation of [18F]RM273 for sigma2-receptor imaging in an experimental orthotopic glioblastoma model Guendel, Daniel

72-73 S p. S184
artikel
224 Evaluation of kit-based synthesis and delivery of 99mTc zoledronic acid as bone cancer imaging radiopharmaceutical Ng, Yen

72-73 S p. S208
artikel
225 Evaluation of 3,4,3-LI(1,2-HOPO) as a chelator for radioscandium based radiopharmaceuticals Phipps, Michael

72-73 S p. S155-S156
artikel
226 Evaluation of neuroinflammatory radiotracers in chronic traumatic encephalopathy Varlow, Cassis

72-73 S p. S109
artikel
227 Evaluation of polyazamacrocycles functionalized with sulphur-containing pendant arms as potential chelators for theranostic silver-111 Tosato, Marianna

72-73 S p. S158
artikel
228 Evaluation of [47Sc]Sc-HOPO toward radioscandium based radiopharmaceuticals Phipps, Michael

72-73 S p. S91-S92
artikel
229 Evaluation of selective Sc(III) complexes with a non-macrocyclic ligand for theranostics applications Huclier, Sandrine

72-73 S p. S56
artikel
230 Evaluation of the binding characteristics of [18F]FBVM in non-human primates, a new radiotracer for imaging the vesicular acetylcholine transporter in vivo using positron emission tomography Serriere, Sophie

72-73 S p. S94-S95
artikel
231 Evaluation of the effect of macrocyclic ring size on Pb(II) and Cu(II) complex stability in pyridyl containing chelators McNeil, Brooke

72-73 S p. S154
artikel
232 Evaluation of the therapeutic effect of taurine against Alzheimer’s disease using mGluR5 PET Lee, Kyo Chul

72-73 S p. S93
artikel
233 Evaluation of the tumour targeting profile and characterisation of the metabolites for a novel stabilised minigastrin analogue Hörmann, Anton

72-73 S p. S194-S195
artikel
234 Evaluation of 44Ti/44Sc generator and 44Sc-post-processing procedures for radiopharmaceutical purposes: [44Sc]Sc-PSMA-617 and [44Sc]Sc-PSMA-I&T synthesis Larenkov, Anton

72-73 S p. S152
artikel
235 Examination of bifunctional chelates for efficient labeling of affibodies with 52Mn Brezovcsik, Karoly

72-73 S p. S147-S148
artikel
236 Examining the synergistic effect of radioimmunotherapy and immune checkpoint blockade for the treatment of metastatic melanoma Allen, Kevin

72-73 S p. S33
artikel
237 Expanding the radiochemist’s toolbox: carbon-11 labelled formamides and isocyanides for PET tracer synthesis Bonnemaire, Coralie

72-73 S p. S10
artikel
238 Experience on clinical scale formulation of ready to use [90Y] Y-hydroxyapatite microparticles utilizing 90Y produced in research reactor Chakraborty, Sudipta

72-73 S p. S140
artikel
239 Exploration of the fundamental chemistries of Ru and Pd for establishing 103Ru/103mRh Auger generator and 103Pd/103mRh in vivo generator Thery, Marie

72-73 S p. S150-S151
artikel
240 Exploration the fluorine chemistry to develop the [18F]FS1P1 as a promise F-18 radiotracer for imaging S1PR1 in vivo Qiu, Lin

72-73 S p. S11-S12
artikel
241 Exploring bpcd ligand for theranostic radiopharmaceutical application Cazzola, Emiliano

72-73 S p. S54
artikel
242 Exploring the chemical scope of light-activated protein conjugation and the photoradiosynthesis of 89Zr-antibodies Earley, Daniel

72-73 S p. S94
artikel
243 Extracorporeal clearing traps based on tetrazine ligation for pretargeted therapy and diagnostics Shalgunov, Vladimir

72-73 S p. S212
artikel
244 Extraction chromatographic separation of selenium and arsenic for accelerator target processing Baumeister, Jakob

72-73 S p. S92-S93
artikel
245 [18F]ALX5406: a brain-penetrating prodrug for GlyT1-specific PET imaging Hoffmann, Chris

72-73 S p. S45
artikel
246 Fast, efficient, one-step purification of cyclotron produced lanthanum-135 using HDEHP-based resin and dilute hydrochloric acid Nielsen, Karin Michaelsen

72-73 S p. S18-S19
artikel
247 18F-Chemistry in HPLC vials - a microliter scale radiofluorination approach Laube, Markus

72-73 S p. S61
artikel
248 [18F]Fluoroform radiolabelling of the CHK1 inhibitor CCT245737 Sharma, Gitanjali

72-73 S p. S48-S49
artikel
249 5-[18F]Fluoro-m-tyrosine (5-[18F]FMT) - a novel promising tracer for dopaminergic imaging Vus, Stefanie

72-73 S p. S38
artikel
250 [18F]FS-DPA: a novel PET probe for imaging of neuroinflammation easily accessible via SuFEx click labeling Walter, Nils

72-73 S p. S110
artikel
251 18F-Functionalization of sulfur heteroatom frameworks via isotopic exchange in hydrous organic media Kim, Min Pyeong

72-73 S p. S37
artikel
252 First-in-human evaluation of [99mTc]Tc-(HE)3-G3, a novel DARPin-based agent for imaging of HER2 expression in breast cancer Tolmachev, Vladimir

72-73 S p. S17-S18
artikel
253 First microvolume metal-mediated synthesis of [18F]FDOPA in a microreactor Lu, Yingqing

72-73 S p. S15-S16
artikel
254 18F-labeled indole-based analogs with chiral 2,3-dihydroxyfluorobutoxy side chain as highly selective sigma-2 receptor probes for tumor imaging An, Xiaodan

72-73 S p. S196-S197
artikel
255 18F labelled albumin binding synthons enabling PET imaging and enhanced target accumulation of biomolecules Hall, Andrew

72-73 S p. S41-S42
artikel
256 18F-labelled probes for non-invasive assessment of the IDH genotype in diffuse glioma Cologni, Roberta

72-73 S p. S17-S18
artikel
257 Fluoride mediated radiosynthesis of [11C]methyl esters Neelamegam, Ramesh

72-73 S p. S73-S74
artikel
258 Fluorinated PET imaging probes targeting fibroblast activation protein: radiolabeling and preclinical evaluation Elvas, Filipe

72-73 S p. S40-S41
artikel
259 Fluoroquinolone dithiocarbamate rhenium and technetium-99m complexes for potential infection imaging agents Shegani, Antonio

72-73 S p. S98
artikel
260 18F-microbubble for PET/US imaging: conception and in vivo imaging Ariztia, Julen

72-73 S p. S166-S167
artikel
261 Foldamers afford improved theranostics targeting cholecystokinin-2 receptor positive cancers Corlett, Alicia

72-73 S p. S16-S17
artikel
262 Formulation and evaluation of human clinical doses of 177Lu-labeled bisphosphonate amide of DOTA using lyophilized kits Chakraborty, Sudipta

72-73 S p. S99-S100
artikel
263 From R&D scale to clinical trial: design of 64Cu-radiolabeled compound production for phase I process Drouin, Guillaume

72-73 S p. S141-S142
artikel
264 [18F]SuFEx-enabled access to an 18F-Labeled PSMA inhibitor intermediate Craig, Austin

72-73 S p. S81
artikel
265 [18F]Talazoparib: a novel potential PET imaging agent of PARP Muzzioli, Riccardo

72-73 S p. S7-S8
artikel
266 Fully automated and GMP-compliant synthesis of [18F]JK-PSMA-7 on a Trasis AllinOne module Ermert, Johannes

72-73 S p. S124
artikel
267 Fully automated macro- and microfluidic production and physiological animal biodistribution of [68Ga]Ga-citrate Ovdiichuk, Olga

72-73 S p. S134-S135
artikel
268 Fully automated purification of labelled antibody on PD-10 cartridges Maindron, Nicolas

72-73 S p. S131-S132
artikel
269 Fully automated radiochemical synthesis of [68Ga]FAPI-4 and its preclinical evaluation for clinical translation Sahu, Sudeep

72-73 S p. S211-S212
artikel
270 Fully automated synthesis of [11C]nicotinamide for in vivo vitamin trafficking studies Shegani, Antonio

72-73 S p. S74-S75
artikel
271 Future prospects for SPECT imaging using the radiolanthanide terbium-155 — production and preclinical evaluation in tumor-bearing mice Müller, Cristina
2014
72-73 S p. e58-e65
nvt p.
artikel
272 [68Ga]Ga-DOTA-C-glycosyl-RGD: synthesis, in vitro evaluation and PET imaging Mengel, Emilien

72-73 S p. S203
artikel
273 [68Ga]Ga-HBED-CC-exendin-4: A new GLP1R targeting radiolabeled agent for pancreas β-cell and insulinoma imaging Li, Linlin

72-73 S p. S47-S48
artikel
274 Ga-68-labelling of quinuclidine triazole-based compound Kanasuwan, Apinan

72-73 S p. S151-S152
artikel
275 Gallium-68 and Copper-64 radiolabelling of hepatotropic GBVA10-9 or CPB peptide derivatives for hepatocellular carcinoma imaging Brossard, Clarisse

72-73 S p. S153
artikel
276 68Ga-radiolabeling of hepatitis E virus-like nanoparticles and evaluation of their ex vivo biodistribution in mice Lambidis, Elisavet

72-73 S p. S106-S107
artikel
277 68Ga-radiolabeling reactions is a media of protic hydroxyalkylammonium ionic liquids based on diethanolammonium salts Antuganov, Dmitrii

72-73 S p. S96-S97
artikel
278 68Ge/68Ga-generator: a radionuclide source or an approved drug? Kvaternik, Herbert

72-73 S p. S100
artikel
279 Genipin enhances 131I-rituximab induced cell cytotoxicity in lymphoma cells Vinod, Nagarajan

72-73 S p. S218
artikel
280 Glucose-albumin nanoplatform for treating renal ischemia-reperfusion injury using reactive oxygen species scavenging properties Park, Ji Yong

72-73 S p. S163
artikel
281 52gMn(II)-Labelled PSMA-ligands as bimodal PET/MR imaging probes Strecker, Jonas

72-73 S p. S157-S158
artikel
282 GMP-compliant radiosynthesis of [18F]GP1 for the detection of thrombi Hugenberg, Verena

72-73 S p. S66
artikel
283 Halogen bond in the context of At-211 radiolabeling: the case of [211At]N-succinimidyl-3-astatobenzoate Yssartier, Thibault

72-73 S p. S159-S160
artikel
284 Harnessing the theranostic potential of lead radioisotopes with sulphur-containing macrocycles Tosato, Marianna

72-73 S p. S158-S159
artikel
285 High affinity novel CXCR4 antagonists radiolabelled with copper-67 and gallium-68 for theragnostic applications Palmer, Max

72-73 S p. S59-S60
artikel
286 Highly automated solid target-based production of the emerging PET isotope cobalt-55 Gé, Lorraine

72-73 S p. S170
artikel
287 Highly modifiable cyclopentadienyl scaffolds for the rapid development of 99mTc radioprobes Lengacher, Rapahel

72-73 S p. S90
artikel
288 High-sensitivity ICP-MS – an alternative for in vitro and in vivo characterization of future radiometal-based theranostic candidates Wallimann, Rahel

72-73 S p. S42-S43
artikel
289 High yield GMP production of [18F]FE-PE2I, a radiotracer for in vivo PET imaging the dopamine transporter Moein, Mohammad Mahdi

72-73 S p. S132-S133
artikel
290 [3H]OF-NB1 and [18F]OF-NB1: novel radioligands for the preclinical assessment of GluN1/2B targeting ligands Ahmed, Hazem

72-73 S p. S95-S96
artikel
291 Hypoxia targeting lutetium-177 labeled gold nanoparticles for cancer theranostic application Mittal, Sweety

72-73 S p. S162-S163
artikel
292 Identifying new antigens on osteosarcoma and developing novel antibodies for radioimmunotherapy Prabaharan, Chandra

72-73 S p. S209-S210
artikel
293 Imaging characterization of National Cancer Institute patient derived xenograft models Drake, Christopher

72-73 S p. S185-S186
artikel
294 Imaging of AAV-mediated gene transfer in the brain using a novel PET reporter gene tracer Stotz, Sophie

72-73 S p. S106-S107
artikel
295 Immune mediated inflammation and perfusion in lungs of Covid-19 patients studied with [11C]GW457427 and [15O]water: a first-in-man pilot study Antoni, Gunnar

72-73 S p. S63
artikel
296 ImmunoPET imaging combined with focused ultrasound to study brain pharmacokinetic of 89Zr labeled anti-PD-L1 antibodies in a syngeneic murine model of glioblastoma Chevaleyre, Céline

72-73 S p. S181-S182
artikel
297 Implementation of iMiDEV, a new fully automated microfluidic platform for radiopharmaceutical production Ovdiichuk, Olga

72-73 S p. S60-S61
artikel
298 Improved droplet-based method for isotopic exchange labeling of trifluoroborate precursors Lisova, Ksenia

72-73 S p. S64-S65
artikel
299 Improved synthesis of [18F]FPATPP via Ru-mediated 18F-Fluorination Rajala, Noora

72-73 S p. S135
artikel
300 111In/225Ac theranostic pretargeting of nodular colorectal peritoneal carcinomatosis: preclinical SPECT and autoradiography studies Chung, Sebastian

72-73 S p. S50
artikel
301 Indigenous preparation, quality control and evaluation of [90Y] Y-glass microspheres for treatment of liver cancer in India Chakraborty, Sudipta

72-73 S p. S180-S181
artikel
302 Influence of pegylation and hapten location at the surface of radiolabelled liposomes on tumour immunotargeting using bispecific antibody Rauscher, A.
2014
72-73 S p. e66-e74
nvt p.
artikel
303 Influence of radiolysis on astatine-211 chemistry Ghalei, Mohammad

72-73 S p. S142
artikel
304 Influence of short PEG linkers on biodistribution of 225Ac-Macropa-YS5, an immunoconjugate for treating CD46 expressing cancer Bobba, Kondapa

72-73 S p. S53
artikel
305 Influence of the conjugation strategy on the stability of 89Zr-labeled immunoconjugates towards radiolysis Vizier, Romane

72-73 S p. S97
artikel
306 Influence of the conjugation strategy on the stability of 89Zr-labeled immunoconjugates towards radiolysis Vizier, Romane

72-73 S p. S120
artikel
307 Initial in vitro study of superparamagnetic iron oxide nanoparticles coated with 198AU for targeted radionuclide therapy and magnetic hyperthermia Zuk, Michal

72-73 S p. S87
artikel
308 Initial results of clinical phase 0 study on [68Ga]Ga-BOT5035/PET for the assessment of fibrosis activity Velikyan, Irina

72-73 S p. S68-S69
artikel
309 Introduction to this Abstract Supplement
72-73 S p. ii
artikel
310 Introduction to this Abstract Supplement
72-73 S p. iii
artikel
311 Investigating the chemical scope of protein-ligation using photoactivatable chelates Earley, Daniel

72-73 S p. S114
artikel
312 Investigating the stereochemical requirements in the design of 68Ga-radiolabelled fibroblast activation protein inhibitors Flores, Jose Esteban

72-73 S p. S187
artikel
313 Investigating the theranostic potential of a novel MUC16-targeted antibody for ovarian cancer Mack, Kyeara

72-73 S p. S58-S59
artikel
314 Investigation of 68Ga/177Lu-labeled FAP-based inhibitor for diagnostic and therapeutic applications Imlimthan, Surachet

72-73 S p. S56-S57
artikel
315 In vitro and in vivo evaluation of a 89Zr-labeled anti-TIP1 antibody Villas Boas, Cristian Wieczorek

72-73 S p. S37-S38
artikel
316 In vitro and preliminary in vivo assessment of monocarboxylate transporter ligand as potential radiotracer for single photon emission computed tomography (SPECT) imaging of triple-negative breast cancer Schmitt, Sébastien

72-73 S p. S205
artikel
317 In-vitro binding assessment of soluble and insoluble tau protein variants with [18F]-AV1451 and [18F]-MK6240 Bansal, Aditya

72-73 S p. S99-S100
artikel
318 In vitro Characterizations of an S1PR1 Specific Radioligand [3H] CS1P1 in the Central Nervous System Jiang, Hao

72-73 S p. S30
artikel
319 In vitro evaluation of 18F-fluorinated D-methionine and D-tyrosine derivatives as potential radiotracers for PET imaging of bacterial infection Betts, Helen

72-73 S p. S63-S64
artikel
320 In vitro evaluation of GPR17 radioligands as potential CNS stem cell imaging agents Kealey, Steven

72-73 S p. S38-S39
artikel
321 In vitro study of 177Lu-DOTA-Trastuzumab and 177Lu-DOTA-Pertuzumab for evaluation of binding affinity towards human cell lines with differential expression of HER-2 receptor Tawate, Megha

72-73 S p. S213
artikel
322 In vivo evaluation of carbon-11 labeled CRANAD-102 as a potential PET tracer for soluble species of amyloid-β species in the brain Staudt, Markus

72-73 S p. S105
artikel
323 In vivo evaluation of carbon-11 labeled 6,7-dimethoxy-1,2,3,4-tetrahydroinsoquinoline derivatives (11C-4-MPTHQ) for potential use as σ2R brain PET tracer Kim, Ho Young

72-73 S p. S40
artikel
324 Isolation of glioblastoma cancer stem cells by sedimentation field flow fractionation for the development of 3D models in supramolecular hydrogels Battu, Serge

72-73 S p. S160
artikel
325 Isotopic fluorine-18 radiolabelling of the anti-retroviral drug dolutegravir for pet imaging Caillé, Fabien

72-73 S p. S64
artikel
326 133/135La-labeling of bleomycin and its initial radiopharmacological evaluation Nelson, Bryce

72-73 S p. S59
artikel
327 Leveraging an open science approach for PET radiotracer discovery: radiolabelling and preliminary neuroimaging of 11C-labelled activin receptor-like kinase 2 inhibitors Murrell, Emily

72-73 S p. S41
artikel
328 Long term experience in [11C]UCB-J production in Turku PET Centre Krzyczmonik, Anna

72-73 S p. S126-S127
artikel
329 177Lu-labeled Lys-urea-Aad-based PSMA-targeting radiotherapeutic agents with low uptake in mouse kidneys and salivary glands Kuo, Hsiou-Ting

72-73 S p. S32-S33
artikel
330 177Lu-labeling of on-resin clicked and cyclized HER2-targeting A9 peptide Sharma, Amit

72-73 S p. S47
artikel
331 [177Lu]Lu-DOTA-A9: A peptide probe targeting HER2 receptors Sharma, Amit

72-73 S p. S47
artikel
332 [177Lu]Lu-labeled gold nanoparticles as tumor hypoxia targeting platforms Mittal, Sweety

72-73 S p. S85-S86
artikel
333 [177Lu]Lu3+ labeling of Erlotinib analogues targeting EGFR-expressing cancers Jain, Akanksha

72-73 S p. S196
artikel
334 Manual labeling, bio-distribution and administration of 177Lu-DOTATE: our long term insight at NORI Bokhari, Ayesha

72-73 S p. S122
artikel
335 Measurements of 186Re production cross section induced by deuterons on natW target at ARRONAX facility Guertin, Arnaud
2014
72-73 S p. e16-e18
nvt p.
artikel
336 Metabolites identification of the selective αvβ3 RGDechi chimeric peptides and their [99mTc][Tc(N)PNP]-derivatives Carpanese, Debora

72-73 S p. S44
artikel
337 Metallaphotoredox aryl and alkyl radiomethylation for PET ligand discovery Graham, Thomas

72-73 S p. S13
artikel
338 mGluR5 exploration in healthy subject by [18F]FPEB Vercouillie, Johnny

72-73 S p. S109
artikel
339 Mild and direct 18F radiofluorination of tetrazines through sulfonium salt precursors Zhang, Wei

72-73 S p. S88-S89
artikel
340 Mild condition radiolabelling and in vivo stability of nanobody constructs with terbium-161 and terbium-155 Cassells, Irwin

72-73 S p. S53-S54
artikel
341 Modification of a commercial radiochemistry module for facile cGMP production of [18F]FET and [18F]FSPG Schulte, Michael

72-73 S p. S135-S136
artikel
342 Molecular imaging for systemic treatment decisions in patients with cancer de Vries, Elisabeth GE

72-73 S p. S1
artikel
343 Molecular imaging of alcoholic liver disease with phosphodiesterase (PDE) 4B targeted [18F]PF-06445974 and positron emission tomography Shao, Tuo

72-73 S p. S18
artikel
344 Molecular imaging of cerebral dysfunction following liver failure with cannabinoid receptor type I targeted [18F]MK-9470 and positron emission tomography Shao, Tuo

72-73 S p. S53-S54
artikel
345 Molecular imaging of LPS induced neuroinflammation with P2x7 targeted [18F]JNJ-64413739 by positron emission tomography Chen, Jiahui

72-73 S p. S92-S93
artikel
346 Molecular imaging of murine liver fibrosis with sphingosine-1-phosphate receptor 1 targeted PET ligand Shao, Tuo

72-73 S p. S55-S56
artikel
347 Molecular imaging of Poly (ADP-ribose) polymerase for nnalcoholic steatohepatitis detection in preclinical models Jeppesen, Troels

72-73 S p. S67-S68
artikel
348 Molecular imaging of PSA using DARPin scaffolds Gut, Melanie

72-73 S p. S190-S191
artikel
349 99mTc-labeled PSMA SPECT CT: a cost effective alternate of PET CT in diagnostic algorithm of prostate cancer Mir, Kahkashan

72-73 S p. S204
artikel
350 99mTc/Re tricarbonyl biguanide complexes for cancer theranostics Xiong, Chiyi

72-73 S p. S58
artikel
351 Multimodal radiobioconjugate - Trastuzumab-PEG-[198Au]AuNPs-PEG-DOX for targeted radionuclide therapy of HER2-positive cancers Żelechowska-Matysiak, Kinga

72-73 S p. S86
artikel
352 Nanoscale microfluidic reactions: towards near-stoichiometric carbon-11 radiolabelling for PET Edgar, Fraser

72-73 S p. S69-S70
artikel
353 New bifunctional linchpin for tandem peptide cyclization/ radiometal incorporation Yuen, Richard

72-73 S p. S120
artikel
354 New CD8 imaging agents to evaluate T-cell infiltration in tumors and predict response to immunotherapy Vivier, Delphine

72-73 S p. S218-S219
artikel
355 New H2dedpa derivatives designed for [67/68Ga]Ga3+ and [64Cu]Cu2+ radiopharmaceutical applications de Guadalupe Jaraquemada-Pelaez, Maria

72-73 S p. S149
artikel
356 NEw materials for conducting radiosynthesis of 18F-compounds Maindron, Nicolas

72-73 S p. S129-S130
artikel
357 New phase transfer agents for fluorine 18 radiolabelling Pelletier, Rémi

72-73 S p. S16-S17
artikel
358 New way to refine direct aromatic 18F-labeling of tetrazines Andersen, Ida

72-73 S p. S76
artikel
359 Next generation therapeutic radiopharmaceuticals targeting cholecystokinin-2 receptor positive cancers Corlett, Alicia

72-73 S p. S16
artikel
360 Noninvasive imaging of STING expression in tumor microenvironment using radioiodinated small molecule Fang, Jianyang

72-73 S p. S52
artikel
361 Novel bifunctional [16]aneS4-derived chelators for soft radiometals Straathof, Natan

72-73 S p. S157
artikel
362 Novel boron-containing amino acid analogs for tumor positron tomography and boron neutron capture therapy Chen, Junyi

72-73 S p. S181
artikel
363 Novel FAPI tracers with albumin-binding properties for cancer imaging and therapy Meng, Lingxin

72-73 S p. S59
artikel
364 Novel folate radioconjugates: optimization of functional units to improve the tissue distribution profile Becker, Anna

72-73 S p. S11-S12
artikel
365 Novel [124I]ATRi VE-821 analogue PET tracer in mouse models for prostate cancer Artschwager, Raik

72-73 S p. S177
artikel
366 Novel 99mTc labelled proline isocyanide derivatives as potential tumour imaging agents Ruan, Qing

72-73 S p. S43-S44
artikel
367 Novel pyrazolethiazole derivatives as new high affinity and selective ligands for alpha-synuclein fibrils as potential PET tracers for Parkinson’s disease Bonanno, Federica

72-73 S p. S90-S91
artikel
368 One batch multiple clinical doses production of [18F]FET with an home-built automated multipurpose [18F]-radiosynthesis module Zheng, Qi-Huang

72-73 S p. S139-S140
artikel
369 One-step automated radiosynthesis of N-succinimidyl-4-[18F]Fluorobenzoate ([18F]SFB) Nagachinta, Surasa

72-73 S p. S117
artikel
370 On the regiochemistry of the synthesis of 18F-labelled difluoroarenes via the copper mediated substitution of tin derivatives Stouse, Adrien

72-73 S p. S36-S37
artikel
371 Optimal ‘hardness’ of non-macrocyclic chelators for [203Pb]Pb2+ radiopharmaceutical applications Ingham, Aidan

72-73 S p. S25
artikel
372 Optimisation of the radiosynthesis of [18F]FDG on MX cassette: application to the dual batch process on NEPTIS® platform Maindron, Nicolas

72-73 S p. S128-S129
artikel
373 Optimization of reaction conditions for the radiolabeling of DOTA and DOTA-peptide with 44m/44Sc and experimental evidence of the feasibility of an in vivo PET generator Huclier-Markai, S.
2014
72-73 S p. e36-e43
nvt p.
artikel
374 Optimization of reaction volumes and reagent amounts for the preparation of various 18F-radiolabelled radiotracers Maindron, Nicolas

72-73 S p. S130
artikel
375 Optimization of the routine production of the ketone body tracer (R)-[11C]3-hydroxybutyric acid Nielsen, Erik

72-73 S p. S23-S24
artikel
376 Optimized pretargeting of [89Zr]Zr-DO3A-proteus radiohapten in rodent models of human colorectal cancer Le Roux, Alexandre

72-73 S p. S3-S4
artikel
377 Optimized QMA-elution enables direct aliphatic 18F-fluorination of highly reactive tetrazines for pretargeted imaging Bratteby, Klas

72-73 S p. S79-S80
artikel
378 Optimized synthesis of tris(hydroxypyridinone)-tetrazine and 68Ga radiolabeling for bioorthogonal chemistry Centanni, Alessia

72-73 S p. S148-S149
artikel
379 Optimizing the reaction conditions for the GMP production of [18F]ACI-12589, a promising candidate in the development as a PET tracer targeting α-synuclein Bratteby, Klas

72-73 S p. S87-S88
artikel
380 Organotin derivatives as versatile precursors for the radioiodination and radiofluorination of 1,2,3,4-tetrahydro-7-hydroxyisoquinoline-3-carboxylic acid (TIC(OH)) analogues Maisonial-Besset, Aurélie

72-73 S p. S17
artikel
381 Original 18F-thiol prosthetic group for labeling of dehydroalanine-containing biologics Richard, Mylène

72-73 S p. S75
artikel
382 3p-C-NETA-TATE: a versatile somatostatin analogue for Al18F-labeled and therapeutic SSTR2 targeting radiopharmaceuticals Ahenkorah, Stephen

72-73 S p. S10-S11
artikel
383 PEGylated liposome encapsulating nido-carborane: boron neutron capture therapy (BNCT) and in vivo trafficking study in animal models Kim, Kyungwon

72-73 S p. S15
artikel
384 PEGylation modulation of peptides promotes PET detection of cancers Hu, Kuan

72-73 S p. S88-S89
artikel
385 Perfluoroaryl azide staudinger reaction combined with sulfur [18F]Fluoride exchange click chemistry for live cell radiolabeling Biti, Anisa

72-73 S p. S78
artikel
386 Performance evaluation of the IRIS XL-220 PET/CT system, a new camera dedicated to non-human primates Boisson, Frédéric

72-73 S p. S173
artikel
387 PET imaging of lung inflammation in pig by neutrophil elastase inhibitor [11C]GW457427 Eriksson, Olof

72-73 S p. S65
artikel
388 PET imaging of neurotensin receptor-positive tumors with 68Ga-labeled antagonists: “the chelate makes again the difference” Renard, Emma

72-73 S p. S6-S7
artikel
389 PET imaging of PD-L1 overexpressing tumors with a 68Ga labeled D-dodecapeptide Hu, Kuan

72-73 S p. S2
artikel
390 Pharmacokinetic, dosimetry and antitumor efficacy of 64Cu/NOTA-terpyridine platinum, a potential radio-chemo-theranostic agent Khosravifarsani, Meysam

72-73 S p. S57
artikel
391 Pharmacokinetic preclinical evaluation of radioligation strategies impact on antibody fragment targeting PD-L1 Truillet, Charles

72-73 S p. S118-S119
artikel
392 PhotoDynamicTherapy by Cerenkov luminescence induct by Gallium-68 on AGuIX@Terbium-porphyrin ultrasmall nanoparticle Collet, Charlotte

72-73 S p. S161
artikel
393 Preclinical assessment of nanoparticles conjugated with 64Cu-DOTA-PEG-BBN targeting gastrin-releasing peptide receptors Niculae, Dana

72-73 S p. S14-S15
artikel
394 Preclinical development of [89Zr]Zr-DFO-Isatuximab as a novel immunoPET tracer for CD38-targeted imaging of multiple myeloma and lymphomas Alvarez, Natalia Herrero

72-73 S p. S192-S193
artikel
395 Preclinical evaluation of [18F]FBVM as a new potent PET tracer for vesicular acetylcholine transporter Vercouillie, Johnny

72-73 S p. S110
artikel
396 Preclinical PET imaging of GSK-3 in pancreatic cancer Boyle, Amanda

72-73 S p. S19
artikel
397 Preclinical validation of [18F]-FB-(Anti Human PD-L1) nanobody for PET imaging Dierick, Herlinde

72-73 S p. S141
artikel
398 Preface of the Workshop on Innovative Personalized Radioimmunotherapy (WIPR 2013) Huclier, Sandrine
2014
72-73 S p. e1-e6
nvt p.
artikel
399 Preliminary evaluation of a novel carbon-11 labeled brain-penetrant EGFR-TKI radiotracer for brain cancer imaging Guttormsen, Yngve

72-73 S p. S42-S43
artikel
400 Preliminary evaluation of 124I labeled virus receptor binding domain Li, Dan

72-73 S p. S50-S51
artikel
401 Preparation and cGMP-compliant production of the bombesin analogue [68Ga]Ga-NOTA-RM26 for first-in-human clinical study of gastrin-releasing peptide receptor expression in prostate cancer Jussing, Emma

72-73 S p. S197-S198
artikel
402 Preparation and characterization and radiolabelling of multivalent ligands towards positron emission tomography imaging of oligomeric forms of misfolded proteins involved in neurodegenerative diseases Thompson, Stephen

72-73 S p. S107-S108
artikel
403 Preparation and multimodality imaging study of 64Cu labeled organic nanoparticles targeting fibroblasts activation protein (FAP) in U87MG model Wen, Li

72-73 S p. S164-S165
artikel
404 Preparation of a 18F-labeled COX-2 inhibitor via [18F]SuFEx reaction Craig, Austin

72-73 S p. S80
artikel
405 Preparation of 211At-labeled aromatic compounds from thioarylprecursors Maingueneau, Clémence

72-73 S p. S43-S44
artikel
406 Preparation of electrodeposited UO2 target for fission-99Mo production Shen, Yijia

72-73 S p. S103-S104
artikel
407 Preparation of 5-[18F],7-difluoro- and 5,7-[18F]difluorotryptophans Kolks, Niklas

72-73 S p. S35
artikel
408 Preparation of radiofluorinated tyrosine derivatives via 18F-SuFEx chemistry and their in vivo evaluation Walter, Nils

72-73 S p. S76
artikel
409 Preparing a 18F-labeled modification of a PD-L1 inhibitor via [18F] SuFEx reaction Craig, Austin

72-73 S p. S80-S81
artikel
410 Pressed chromium/sodium fluoride target for cyclotron production of manganese-52 Nielsen, Karin Michaelsen

72-73 S p. S102-S103
artikel
411 Process validation of Ga-68 labelled FAPI-46 at HUS Diagnostic Center Koivula, Teija

72-73 S p. S143-S144
artikel
412 Production and application of the 203Pb/212Pb theranostic pair at TRIUMF McNeil, Brooke

72-73 S p. S95-S96
artikel
413 Production and characterization of high purity radioscandium isotopes, 43,47Sc, of clinical interest from proton bombardment on enriched [46,50Ti]TiO2 targets Cingoranelli, Shelbie

72-73 S p. S49-S50
artikel
414 Production and radiochemical separation of terbium-155 from enriched gadolinium target material and its preliminary application in SPECT imaging Favaretto, Chiara

72-73 S p. S50-S51
artikel
415 Production of emerging theranostic radionuclides at TRIUMF Radchenko, Valery

72-73 S p. S172
artikel
416 Production of 117mSn using Sb alloy targetry Baumeister, Jakob

72-73 S p. S23-S24
artikel
417 Production of Strontium-85 via deuteron-induced nuclear reactions on natural rubidium Tanzey, Sean

72-73 S p. S22
artikel
418 Production of 89Zr from cyclotron using yttrium foil: a new target design Pandey, Mukesh

72-73 S p. S103
artikel
419 Promising potential 68Ga-labeled small-molecular tracers for immune checkpoint ligand PD-L1 expression in tumor Lu, Jie

72-73 S p. S199
artikel
420 Protein 18F radiolabelling by Snap-Tag: synthesis and radiofluorination of O6-benzylguanine derivatives Ariztia, Julen

72-73 S p. S77
artikel
421 Quantification of radiotracer accumulation in a dynamic column-based 3D cell culture Pichler, Verena

72-73 S p. S14
artikel
422 Quantitation of a CB1R tracer [18F]FPATPP with radioLC/MS/MS Lahdenpohja, Salla

72-73 S p. S174
artikel
423 Quick determination of 90SR/90Y for application in nuclear medicine by counting gross-beta activity Tuan, Hoang

72-73 S p. S172
artikel
424 Radioactive Isotopes for Cancer Radiotherapy Hoehr, Cornelia

72-73 S p. S2
artikel
425 Radiobioconjugates of 193m,195mPt nanoparticles for combined “chemo-Auger electron” therapy of hepatocellular carcinoma (HCC) and HER2+ breast and ovarian cancers Wawrowicz, Kamil

72-73 S p. S48
artikel
426 Radiochemical aspects of synthesis and analysis of [177Lu]Lu-PSMA-617 and [177Lu]Lu-PSMA-I&T single-dose preparations Larenkov, Anton

72-73 S p. S152
artikel
427 Radiochemical formulation of 177Lu-DOTA-trastuzumab: using low specific activity 177LuCl3 Tawate, Megha

72-73 S p. S146
artikel
428 Radiochemical synthesis and automation of an 18F-radiolabelled oligonucleotide for PET imaging of miRNA-223 in relation to neuroinflammation Zientek, Simon

72-73 S p. S113-S114
artikel
429 Radiochemical synthesis of [18F]Fluoroanilines via flow reduction Wilde, Justin

72-73 S p. S139
artikel
430 Radiofluorination of Ruppert-Prakash reagent (Me3SiC[18F]F3) for syntheses of 18F-trifluoromethylated compounds Pees, Anna

72-73 S p. S23
artikel
431 Radioiodinated and astatinated NHC rhodium complexes: Synthesis Rajerison, Holisoa
2014
72-73 S p. e23-e29
nvt p.
artikel
432 Radioisotope-loaded microbubbles for cancer imaging and therapy Gower-Fry, Kaley

72-73 S p. S149-S150
artikel
433 Radiolabeled chimeric interlukine-1 (IL-1) receptor antagonist for imaging tumor microenvironment of colorectal cancer Liu, Zhonglin

72-73 S p. S202
artikel
434 Radiolabeling and biological evaluation of functionalized spherical nucleic acids Auchynnikava, Tatsiana

72-73 S p. S39-S40
artikel
435 Radiolabeling and evaluation of cyclohexyl (5-(2-acetamidobenzo[d]thiazol-6-yl)-2-methylpyridin-3-yl) carbamate (PK68), a potent inhibitor for receptor interacting protein 1 kinase (RIPK1) Kumata, Katsushi

72-73 S p. S113
artikel
436 Radiolabeling and evaluation of 68Ga-DOTA-F56 peptide targeting vascular endothelial growth factor receptor Zhang, Qian

72-73 S p. S222
artikel
437 Radiolabeling and preclinical evaluation of a novel PET ligand for imaging phosphodiesterase (PDE) 4B Chen, Jiahui

72-73 S p. S91-S92
artikel
438 Radiolabeling of HTE1PA: A new monopicolinate cyclam derivative for Cu-64 phenotypic imaging. In vitro and in vivo stability studies in mice Frindel, Mathieu
2014
72-73 S p. e49-e57
nvt p.
artikel
439 Radiolabeling of small molecules and peptides with therapeutic radionuclide Cu-67 for theranostic applications Pike, Susan

72-73 S p. S156
artikel
440 Radiolabelling of biomolecules with an original exo-maleimide prosthetic group Richard, Mylène

72-73 S p. S117-S118
artikel
441 Radiolabelling of DOTA-Kisspeptin with gallium-68 and lutetium-177 Kleynhans, Janke

72-73 S p. S143
artikel
442 Radiopharmaceutical preparation and quality control of 225Ac-DOTAGA-IAC for tumor targeted alpha therapy (TAT) Pandey, Somit

72-73 S p. S144-S145
artikel
443 Radiosynthesis and biological evaluation of a nicotinic acid hydroxamate derivative as a radioligand for HDAC6 PET imaging Tago, Tetsuro

72-73 S p. S107
artikel
444 Radiosynthesis and biological evaluation of 10-[11C] methoxy-berberine as a novel PET tracer for visualizing berberine metabolism and distribution in mice Zhang, Xiaojun

72-73 S p. S69
artikel
445 Radiosynthesis and biological evaluation of [18F]CooP: a brain-homing peptide for imaging glioblastomas using positron emission tomography Dillemuth, Pyry

72-73 S p. S18-S19
artikel
446 Radiosynthesis and biological evaluation of [18F]R91150, a selective 5-HT2A receptor antagonist for PET imaging Willmann, Michael

72-73 S p. S35-S36
artikel
447 Radiosynthesis and biological investigation of an 18F-labeled triazolopyridopyrazine-based inhibitor for imaging of the phosphodiesterase 2A enzyme (PDE2A) in brain Wenzel, Barbara

72-73 S p. S111
artikel
448 Radiosynthesis and first preclinical evaluation of an 18F-radiolabelled ligand for cancer stem cells non-invasive PET imaging Toussaint, Magali

72-73 S p. S216
artikel
449 Radiosynthesis and in vitro evaluation of [99mTc]-labeled hyaluronic acid derivatives Sarasamkan, Jiradanai

72-73 S p. S156-S157
artikel
450 Radiosynthesis and preclinical biodistribution of a carbon-11-labelled STING agonist Hill, James

72-73 S p. S193
artikel
451 Radiosynthesis, in vitro and in vivo evaluations of [3H]/[18F]CBD-2115 as first in class radiotracers for imaging 4R-tauopathies Lindberg, Anton

72-73 S p. S9-S10
artikel
452 Radiosynthesis of [11C]EHT1610, a potential radioligand for quantification of cerebral DYRK1A by PET imaging POUTREL, Pauline

72-73 S p. S95
artikel
453 Radiosynthesis of 6-(2-cyclobutyl-5-(methyl-11C)-3H-imidazo[4,5-b]pyridin-3-yl)benzo[d]thiazol-2(3H)-one and (2-cyclobutyl-3-(1H-indazol-5-yl)-5-[11C]methyl-3H-imidazo[4,5-b]pyridine for imaging γ-8 dependent transmembrane AMPA receptor regulatory protein Yu, Qingzhen

72-73 S p. S97-S98
artikel
454 Radiosynthesis of [18F]2- and [18F]4-fluoro[1,3]-pyrimidines Kumar, Dileep

72-73 S p. S82-S83
artikel
455 Radiosynthesis of [18F]fluoroadenosine derivative : a new imaging agent for HSP70 Ghosh, Pradip

72-73 S p. S72-S73
artikel
456 Radiosynthesis of [18F]FP-CIT using azetidinium salt precursor and evaluation of radiochemical purity and stability Kim, Dong Hyun

72-73 S p. S126
artikel
457 Radiosynthesis of 18F labelled D-amino acid tracers and their use for bacteria imaging Sorlin, Alexandre

72-73 S p. S68
artikel
458 Radiosynthesis of [18F]talazoparib and biodistribution study in PC3 prostate tumor mice Zhou, Dong

72-73 S p. S45
artikel
459 Radiosynthesis of [18F]VU6010572 as a PET radiotracer for imaging metabotropic glutamate receptor 3 (mGluR3) Rong, Jian

72-73 S p. S100-S101
artikel
460 Radiosynthesis of new PET tracer targeting macrophage mannose receptor Andriana, Putri

72-73 S p. S62-S63
artikel
461 Radiosynthesis of novel PET tracers for α-synuclein imaging Hoang, Anh

72-73 S p. S96
artikel
462 223Ra-radiolabeling: predicting stability using molecular modelling Mohaman, Hamissou

72-73 S p. S154-S155
artikel
463 64 reactions in an hour using an automated, robotic high-throughput radiochemistry optimization platform Jones, Jason

72-73 S p. S59
artikel
464 Reducing protodeboronation using a novel boronic ester in the late-stage copper-mediated radiofluorination Jaworski, Carolin

72-73 S p. S46-S47
artikel
465 Reducing the renal retention of 111In-labelled fibronectin-binding peptides through brush border-enzyme sensitive cleavable linkers Valpreda, Giulia

72-73 S p. S34-S35
artikel
466 Re/99mTc complexes of 1,8-naphthalimide with varying linkers as dual-modality imaging agents Prabhu, Priyanka Jagadeesa

72-73 S p. S41-S42
artikel
467 Replacing high-performance liquid chromatography (HPLC) with high-resolution thin layer chromatography (TLC) for rapid radiopharmaceutical analysis Holloway, Travis

72-73 S p. S63
artikel
468 Scandium-47 and lutetium-177 radiolabelling and stability studies of 1st and 2nd generation DOTA-triphenylphosphonium ligands – potential radionuclide theranostics for treatment of glioblastoma multi-forme Wyatt, Naomi

72-73 S p. S93-S94
artikel
469 Scandium exopolysaccharide complexes: evaluation of antiproliferative properties of on several cancer cell lines Munoz-Garcia, Javier

72-73 S p. S195-S196
artikel
470 SCIFI: exciting BODIPY compounds with 89Zr-generated Cerenkov radiation Gristwood, Katie

72-73 S p. S167
artikel
471 Short PEG linkers considerably reduce background noise in immuno-PET tumor imaging Nam, Bora

72-73 S p. S207
artikel
472 Silicon-based Fluoride Acceptor (SiFA) on solid supports: a new versatile tool for 18F-fluorination of peptides and biological structures Steffann, Marine

72-73 S p. S87
artikel
473 Simple and quick indirect radioiodination to antibody without HPLC purification using fluorous solid-phase extraction and click reaction Im, Changkeun

72-73 S p. S125-S126
artikel
474 Simple and rapid automated synthesis of L-[11C]glutamine Fujinaga, Masayuki

72-73 S p. S124-S125
artikel
475 Simple method for the production of [11C]phosgene Krzyczmonik, Anna

72-73 S p. S72-S73
artikel
476 Site-selective 18F-labelling of octreotide via disulfide rebridging Richard, Mylène

72-73 S p. S86
artikel
477 Site-selective labelling of biomolecules via disulfide rebridging Richard, Mylène

72-73 S p. S4
artikel
478 Site-specific radiofluorination of peptides via chemoselective S-arylation with 4-[18F]Fluoroiodobenzene Francis, Felix

72-73 S p. S116
artikel
479 Site-specific radiolabeling of an anti-HER2 single domain antibody fragment with an 211At-labeled prosthetic agent: preliminary evaluation of a potential targeted α-particle therapeutic Feng, Yutian

72-73 S p. S32
artikel
480 Small molecule-based angiogenic radiotracer for early detection and progression management of pulmonary arterial hypertension Yang, Zhen

72-73 S p. S67
artikel
481 Solid phase radiosynthesis of an 18F labeled olaparib derivative for PET imaging of PARP expression Zhou, Dong

72-73 S p. S222
artikel
482 Solid polyamine adsorbents for [11C]CO2 capture, purification, and radiosynthesis Chasse, Melissa

72-73 S p. S23
artikel
483 Sortase mediated conjugation and 89Zr-radiolabelling of the HER2 neu targeting G3-DARPin for in vivo PET imaging in BT-474-xenografts Fay, Rachael

72-73 S p. S89-S90
artikel
484 SPAAC incorporation of fluorine into FC131 analogues towards discovery of CXCR4 radiopharmaceuticals Mason, Julia

72-73 S p. S202-S203
artikel
485 Specific imaging of bacterial infections with 18F-labeled maltotriose ([18F]AAX90) Landau, Felicitas

72-73 S p. S8
artikel
486 Structure-activity relationship of pyrazol-4-yl-pyridine derivatives for imaging the muscarinic acetylcholine receptor M4 Haider, Ahmed

72-73 S p. S25
artikel
487 Structure-activity relationship study of peptide Gastramide-01 (GA-01), a potent binder of cholecystokinin-2 (CCK-2) receptor and theranostic candidate Rahimi, Marwa

72-73 S p. S107
artikel
488 Studies on the novel scandium-47 labelled PSMA inhibitor targeting ligand Wojdowska, Wioletta

72-73 S p. S102
artikel
489 Studying the effect of structural modification of porphyrin derivatives on tumor uptake: Is lipophilicity the sole criterion? Guleria, Mohini

72-73 S p. S45-S46
artikel
490 Subtype-selective vasopressin 1A receptor imaging by positron emission tomography Haider, Ahmed

72-73 S p. S58
artikel
491 Supramolecular chemistry in the synthesis of radiopharmaceuticals d’Orchymont, Faustine

72-73 S p. S34
artikel
492 Synthesis and Astatine Labeling of a bis-iminobiotin derivative with enhanced plasma stability Washiyama, Kohshin

72-73 S p. S121
artikel
493 Synthesis and bioevaluation of a novel SPECT agent targeting breast cancer estrogen receptor Lin, Xiaoru

72-73 S p. S53
artikel
494 Synthesis and biological evaluation of a novel radioligand [11C] BIO-1790735 for detection of O-GlcNAcase (OGA) enzyme activity Nag, Sangram

72-73 S p. S26
artikel
495 Synthesis and characterization of new hydrophilic trithiol chelates and their radioarsenic complexes Ma, Li

72-73 S p. S30
artikel
496 Synthesis and characterization of novel enrofloxacin derivatives and their rhenium and technetium-99m tricarbonyl complexes as potential therapeutic or diagnostic agents Tzovas, Georgios

72-73 S p. S99
artikel
497 Synthesis and evaluation of a bivalent radiohapten for DOTA-based pretargeted radioimmunotherapy Veach, Darren

72-73 S p. S61-S62
artikel
498 Synthesis and evaluation of a [68Ga]Ga-labeled water soluble porphyrin as a tumor targeting theranostic agent: in-vitro and in-vivo studies Kumar, Naveen

72-73 S p. S183-S184
artikel
499 Synthesis and evaluation of an 18F labeled conformationally flexible benzamide analog ([18F]Fluoroethyl HY-2-92) for D3R PET Studies Kim, Ho Young

72-73 S p. S96-S97
artikel
500 Synthesis and evaluation of a radioligand for PET imaging of hepsin Park, Ji-Hun

72-73 S p. S183
artikel
501 Synthesis and evaluation of 18F-labeled tracer candidates targeting the Abelson non-receptor tyrosine kinase in Parkinson’s disease Stéen, E. Johanna

72-73 S p. S27
artikel
502 Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for amyloid PET-imaging Schlein, Eva

72-73 S p. S101-S102
artikel
503 Synthesis and evaluation of 68Ga-labeled [Leu13ψThz14] Bombesin(7-14) analogues for imaging gastrin-releasing peptide receptor expression with positron emission tomography Wang, Lei

72-73 S p. S219
artikel
504 Synthesis and evaluation of novel 18F-labeled indole-based derivatives as sigma-2 receptor radioligands for imaging the proliferative status of tumors Zhang, Ying

72-73 S p. S197
artikel
505 Synthesis and evaluation of novel PET ligands for imaging Orexin2 receptor (OX2R) Rong, Jian

72-73 S p. S101
artikel
506 Synthesis and evaluation of PET ligands for monoacylglycerol lipase in brain Mori, Wakana

72-73 S p. S99
artikel
507 Synthesis and evaluation of [186Re]Re(CO)3-p-NCS-benzyl-NODAGA-Ser2-RM2 for future development as a GRPR-antagonist for targeting prostate cancer Hoerres, Rebecca

72-73 S p. S90-S91
artikel
508 Synthesis and in vitro and in vivo evaluation of a new 64Cu-semicarbazone complex: potential theranostic radiopharmaceutical for hypoxic tumor Aljammaz, Ibrahim

72-73 S p. S52
artikel
509 Synthesis and in vivo characterization of a heterobivalent radiotracer targeting PSMA and GRPR for prostate cancer imaging Bailly, Thibaud

72-73 S p. S177-S178
artikel
510 Synthesis and optimization of radiotracers targeting P2Y12 receptors for positron emission tomography imaging of neuroinflammation Pincemail, Eugénie

72-73 S p. S99-S100
artikel
511 Synthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor Högnäsbacka, Antonia

72-73 S p. S38-S39
artikel
512 Synthesis and preclinical evaluation of [methylpiperazine-11C]brigatinib as a PET imaging agent for mutated EGFR and ALK positive tumors Högnäsbacka, Antonia

72-73 S p. S51-S52
artikel
513 Synthesis and preclinical evaluation of PD-L1 PET tracer [18F]FDHPA in mice Tong, Jie

72-73 S p. S214
artikel
514 Synthesis and preliminary evaluation of novel aminoimidazoline derivatives targeting the norepinephrine transporter Lu, Jie

72-73 S p. S199
artikel
515 Synthesis and preliminary in-vitro studies of [99mTc][TcN(PNP)]-biphosphonates as new bone-radiopharmaceuticals. Carpanese, Debora

72-73 S p. S44-S45
artikel
516 Synthesis and radiofluorination of [18F]F-BAY-8002: a novel potential radiotracer for PET imaging of monocarboxylate transporter 1 Sadeghzadeh, Masoud

72-73 S p. S74-S75
artikel
517 Synthesis and radiolabeling of a novel decadentate ligand 3,4,3,3-(LI-1,2-HOPO) Carbo-Bague, Imma

72-73 S p. S12-S13
artikel
518 Synthesis and radiolabeling of [11C]CP31398 and fluorine-18 derivatives for PET imaging targeting p53 Beuché, Sébastien

72-73 S p. S180
artikel
519 Synthesis and radiolabeling of ultrasmall gold nanoparticles for in vivo tracking of radiosensitizing agents in radiation therapy Kiseleva, Mariia

72-73 S p. S84
artikel
520 Synthesis and radiolabeling with carbon-11 of original covalent inhibitors of focal adhesion kinase for PET imaging Beuché, Sébastien

72-73 S p. S70-S71
artikel
521 Synthesis and radiolabelling of the anti-retroviral drug dolutegravir with fluorine-18 for PET imaging of HIV-1 reservoirs Tisseraud, Marion

72-73 S p. S78
artikel
522 Synthesis of a carbon-11 labeled metabotropic glutamate receptor 7 ligand for PET neuroimaging Xiao, Zhiwei

72-73 S p. S112
artikel
523 Synthesis of a carbon-11 labeled spiro-quinazolinone based PDE7 ligand for PET neuroimaging Xiao, Zhiwei

72-73 S p. S111-S112
artikel
524 Synthesis of a 11C-labeled ketone through intermolecular arene C–H carbonylation from 4-iodotoluene and 1-methylindole Lu, Shuiyu

72-73 S p. S73
artikel
525 Synthesis of a new 6-substituted 4-anilinoquinazoline derivative as irreversible inhibitor for EGFR imaging Makrypidi, Konstantina

72-73 S p. S209
artikel
526 Synthesis of a PSMA-targeting ligand with an optimized linker for imaging and treatment of prostate cancer Murce, Erika

72-73 S p. S206-S207
artikel
527 Synthesis of [11C]aryl nitriles via [11C]aryl amides Gonzalez, Miguel Cortes

72-73 S p. S71
artikel
528 Synthesis of [11C]Me-DPA and evaluation in transgenic mouse model of Alzheimer’s disease Keller, Thomas

72-73 S p. S25-S26
artikel
529 Synthesis of [18F]FPATPP via Cu-mediated 18F-fluorination Lahdenpohja, Salla

72-73 S p. S73-S74
artikel
530 Synthesis of fluorine-18 labeled glycogen synthase kinase-3 inhibitors and preliminary PET neuroimaging in rodent and non-human primate Varlow, Cassis

72-73 S p. S31-S32
artikel
531 Synthesis of fluorine-18 labelled tetrazine and coupling to trans-cyclooctene functionalized Affibody molecules Zhang, Bo

72-73 S p. S115
artikel
532 Synthesis of [18F]MK7246 for beta cell mass imaging Parker, Candace

72-73 S p. S40-S41
artikel
533 Synthesis of [18F]Togni reagent I, a new electrophilic [18F] trifluoromethylation synthon Haveman, Lizeth

72-73 S p. S15-S16
artikel
534 Synthesis of [18F]UCB-J Keller, Thomas

72-73 S p. S82
artikel
535 Synthesis of gold nanoparticles labeled with Auger electron emitters: 197Hg/197mHg as potential therapeutic radiopharmaceuticals Majka, Emilia

72-73 S p. S162
artikel
536 Synthesis of N-methyl- and 5-OH-[18F]fluorotryptophans Kolks, Niklas

72-73 S p. S34-S35
artikel
537 Synthesis of novel selective histone deacetylase inhibitors for the development of a suitable 18F-labelled radiotracer for the molecular imaging of HDAC1 in brain tumours Clauß, Oliver

72-73 S p. S215-S216
artikel
538 Synthesis of [13N]-Oxytocin for human intranasal administration Jakobsen, Steen

72-73 S p. S125
artikel
539 Synthesis of PET tracers for imaging of thiocyanate efflux from the brain Okamura, Toshimitsu

72-73 S p. S74
artikel
540 Synthesis of radiopharmaceuticals (At-AITM) for melanoma with overexpressed metabotropic glutamate receptor 1 Hanyu, Masayuki

72-73 S p. S173-S174
artikel
541 Synthesis, radiolabeling and biological evaluation of a novel trace amine-associated receptor 1 (TAAR1) PET radioligand Haider, Ahmed

72-73 S p. S37-S38
artikel
542 Synthesis, radiolabeling and fluorescence imaging of new fluorine-18 derivatives of MeDAS for PET imaging of demyelination Beuché, Sébastien

72-73 S p. S89-S90
artikel
543 Synthesis, radiolabeling and metabolism of new fluorine-18 derivatives of MeDAS for PET imaging of demyelination Beuché, Sébastien

72-73 S p. S72-S73
artikel
544 Synthesis, radiolabelling and complex formation of the novel chelator DOTI-Me with Cu, In, Ga Hierlmeier, Ina

72-73 S p. S4-S5
artikel
545 Synthesis/radiosynthesis and evaluation of three 18F radiotracers for imaging of sphingosine-1-phosphate receptor 1 Qiu, Lin

72-73 S p. S4
artikel
546 Synthetic methodologies toward fibroblast activation protein inhibitors and radiolabelling with 68Ga, 64Cu or 89Zr Flores, Jose Esteban

72-73 S p. S94-S95
artikel
547 Table of Contents
72-73 S p. iv
artikel
548 Targeted 212Pb therapy in prostate cancer xenograft mouse model using a novel clinical-stage human monoclonal antibody Li, Jun

72-73 S p. S192
artikel
549 Targeted radioimmunotherapy of PD1+ cells for the treatment of multiple sclerosis Frank, Connor

72-73 S p. S4-S5
artikel
550 Targeting LDLR-overexpressing glioblastoma and pancreatic ductal adenocarcinoma Tworowska, Izabela

72-73 S p. S217-S218
artikel
551 Targeting the kynurenine pathway for tumour characterization by PET and SPECT Foscolos, Angeliki

72-73 S p. S182-S183
artikel
552 Targeting α2δ1 with a 64Cu-NOTA-1B50-1-F(ab`)2 enables in vivo PET imaging of liver cancer stem cells Guo, Xiaoyi

72-73 S p. S189-S190
artikel
553 Tetrazine ligation based pretargeting strategy for core-labeled polymeric micelles Sporer, Emanuel

72-73 S p. S13-S14
artikel
554 232Th(d,4n)230Pa cross-section measurements at ARRONAX facility for the production of 230U Duchemin, C.
2014
72-73 S p. e19-e22
nvt p.
artikel
555 The bioconjugation of a radioiodinated silicon rhodamine as multimodal imaging probe for SPECT and NIR imaging Kanagasundaram, Thines

72-73 S p. S168-S169
artikel
556 The biodistribution of [18F]BPA in nude mice bearing U87MG glioma Fenglin, Li

72-73 S p. S101-S102
artikel
557 The development of a dual-modality (PET/NIR) radioimmunoconjugate for image-guided sarcoma surgery Pringle, Toni

72-73 S p. S169
artikel
558 The development of heparanase-targeting radiotracers for PET imaging Pu, Yinglan

72-73 S p. S210
artikel
559 The effect of base strengths on the radiochemical yields of S[18F]FB synthesis Al-Qahtani, Mohammed

72-73 S p. S75-S76
artikel
560 The first radioiodinated protein affinity probe for estrogen receptor targeted breast cancer imaging Fang, Jianyang

72-73 S p. S52-S53
artikel
561 The influence of terminal amine groups in close proximity to the metal chelator in peptide derived radiopharmaceuticals on the radiolabelling with 68Ga and 64Cu Hierlmeier, Ina

72-73 S p. S150
artikel
562 Theoretical evaluation of losartan derivatives with polar sidechains as candidates of radiopharmaceutical Fleitas, Ariel Garcia

72-73 S p. S79
artikel
563 The production of radionuclides for nuclear medicine from a compact, low-energy accelerator system Webster, William D.
2014
72-73 S p. e7-e15
nvt p.
artikel
564 The production of 161Tb and its introduction to the clinic through the Good Manufacturing Practice-compliant radiolabeling of [161Tb]Tb-DOTATOC Favaretto, Chiara

72-73 S p. S62-S63
artikel
565 The radiolabeling of silicon rhodamines for multimodal PET/ SPECT- and NIR optical imaging Kanagasundaram, Thines

72-73 S p. S81
artikel
566 Theranostic tetrazines: radiosynthesis and evaluation of aromatic 18F/211At pair highly reactive tetrazines for pretargeted bioorthogonal PET imaging and targeted alpha-therapy Vázquez, Rocío García

72-73 S p. S55-S56
artikel
567 The synthesis and bioevaluation of a novel and brain penetrable PARP1 tracer [18F]Pamiparib in rodents and nonhuman primates Tong, Jie

72-73 S p. S214-S215
artikel
568 The value of 18F-FDG PET/CT in differential diagnosis of pulmonary sclerosing pneumocytoma and pulmonary carcinoids Zhang, Annan

72-73 S p. S49-S50
artikel
569 Thin layer chromatography for rapid purification and reformulation of microfluidically-produced radiopharmaceuticals Holloway, Travis

72-73 S p. S63-S64
artikel
570 Title Page
72-73 S p. ii
artikel
571 Toward a reproductive and automated radiolabelling with {Al18F}2+ complex? A full comparison with the radiolabelling of small molecules Schmitt, Sébastien

72-73 S p. S86-S87
artikel
572 Towards Actinium-225 production at SCK CEN Skliarova, Hanna

72-73 S p. S80-S81
artikel
573 Towards an improved methodology for separating mercury-197 from proton-irradiated gold targets – a study of mercury adsorption behaviour on different extraction resins in hydrochloric acid Chen, Shaohuang

72-73 S p. S93
artikel
574 Towards bifunctional technetium isonitrile complexes Claude, Guilhem

72-73 S p. S9-S10
artikel
575 Trafficking of orally administered vitamins in mice with positron emission tomography Bongarzone, Salvatore

72-73 S p. S56-S57
artikel
576 Trans-cyclooctene modified antibodies for pretargeted imaging of amyloid-β van den Broek, Sara Lopes

72-73 S p. S98-S99
artikel
577 Transition-metal-free reductive coupling of an 18F-labeled nitro-arene with boronic acids as a potential access to 18F-labeled fenamates Laube, Markus

72-73 S p. S74
artikel
578 Translating radioimmunotherapy from cancer to infectious diseases Dadachova, Ekaterina

72-73 S p. S64-S65
artikel
579 Translational PET imaging evaluation of [18F]Favipiravir by positron emission tomography Rong, Jian

72-73 S p. S54
artikel
580 Translation of [68Ga]Ga-PSMA-11 radiosynthesis on the microfluidic system iMiDEVTM Ovdiichuk, Olga

72-73 S p. S134
artikel
581 Translation of New Chemical Methods and Radiopharmaceuticals for Neuroimaging Vasdev, Neil

72-73 S p. S2
artikel
582 Trastuzumab-conjugated oxine-based ligand for [89Zr] Zr4+-immunoPET Southcott, Lily

72-73 S p. S9
artikel
583 TRIHOPO: 1,2-HOPO-based macrocyclic chelator for 225Ac, 227Th, and 89Zr Fiaccabrino, Desiree

72-73 S p. S55
artikel
584 Tumor cell imaging with derivatives of Senicapoc targeting KCa3.1 channels Konken, Christian

72-73 S p. S76-S77
artikel
585 Tumor-specific delivery of radioligands targeting carbonic anhydrase-IX utilizing albumin binder Iikuni, Shimpei

72-73 S p. S25-S26
artikel
586 Tumor stroma diagnostic imaging by a 68Ga-coupled small-molecule fibroblast activation protein (FAP) inhibitor: first pre-clinical data Escudero-Castellanos, Alondra

72-73 S p. S186-S187
artikel
587 Two HER2 PET tracers: Al18F-NOTA-HER2-BCH and Al18F-RESCA-HER2-BCH were compared Liu, Jiayue

72-73 S p. S201-S202
artikel
588 Uncovering the role of modified citrus pectin in cancer da Silva, Fábio Alves

72-73 S p. S176-S177
artikel
589 Using high-specific activity Samarium-153 for the development of [153Sm] Sm DOTA-TATE for targeted radionuclide therapy of neuroendocrine tumors Vermeulen, Koen

72-73 S p. S20
artikel
590 Utilizing click chemistry for PET infection imaging by fluorine-18 labeling of azide-modified bacteria Alanizi, Aryn

72-73 S p. S62
artikel
591 Water-soluble [Tc(N)(PNP)]-moiety for the room temperature labeling of sensitive molecules Bolzati, Cristina

72-73 S p. S147
artikel
592 What a difference an additional methylene makes: replacing Glu with Aad in the Lys-urea-Glu pharmacophore to reduce kidney and salivary gland uptake of PSMA-targeting radiopharmaceuticals Kuo, Hsiou-Ting

72-73 S p. S200
artikel
593 86Y/90Y-labeled ultrasmall porous silica nanoparticles with enhanced pharmacokinetics for cancer theranostics Cai, Weibo

72-73 S p. S160-S161
artikel
594 89Zr cyclotron-based production by a suitable Y solid target Cisternino, Sara

72-73 S p. S12
artikel
595 89Zr-immuno-PET of a novel bispecific amyloid-β monoclonal antibody reveals improved and high specific brain uptake Stergiou, Natascha

72-73 S p. S30-S31
artikel
596 89Zr-photoradiosynthesis of a dual-modality PET-optical tracer using light-induced antibody conjugation chemistry Guillou, Amaury

72-73 S p. S21-S22
artikel
597 89Zr radiolabeling of antibodies targeting trachea colonization factor A for immuno-PET imaging of Bodetella pertussis in whooping cough infection Caillé, Fabien

72-73 S p. S55
artikel
598 [89Zr]Zr-DFO-denosumab immuno-PET validation in the tumor microenvironment of human ME-180 xenografts Dewulf, Jonatan

72-73 S p. S1
artikel
599 [89Zr]ZrTrastuzumab automatic preparation on commercial cassette base synthesis module Cazzola, Emiliano

72-73 S p. S122
artikel
                             599 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland